Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00397592 · ClinicalTrials.gov registry record · NA
Growth Hormone's Effect on Endothelial Progenitor Cells
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT00397592 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 18 participants.
The verdict
NCT00397592, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
To assess the effect of short-term low-dose growth hormone therapy on the mobilization of endothelial progenitor cells from the bone marrow within a group of healthy adults.
Interventions
- DRUG Growth Hormone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2006-08 |
| Est. Completion | 2007-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00397592
The ClinicalTrials.gov registry entry for NCT00397592 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Growth Hormone is the first listed.
NCT00397592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00397592 about?
NCT00397592 is a clinical study titled "Growth Hormone's Effect on Endothelial Progenitor Cells". To assess the effect of short-term low-dose growth hormone therapy on the mobilization of endothelial progenitor cells from the bone marrow within a group of healthy adults.
What is the current status of trial NCT00397592?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2006-08. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00397592?
The interventions under investigation include: Growth Hormone (DRUG).
Who is sponsoring clinical trial NCT00397592?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.